Quick Facts
  • Primary Location:
    Alvin J. Siteman Cancer Center
  • Expertise:
    Lung Cancer
    Research
  • Speciality:
    Thoracic Surgery
  • Gender:
    Male
  • Language:
    English
  • Med School:
    University of Rochester

Get to Know Dr. Benjamin Kozower

Treating lung cancer is one of Dr. Benjamin Kozower’s specialties. He takes a personalized approach to medicine and always considers ways to improve the treatment and follow-up care he provides.

Health services research is part of his work at Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

Siteman is the only cancer center in Missouri with the prestigious Comprehensive Cancer Center designation from the National Cancer Institute. It provides care for close to 10,000 cancer patients each year with a full range of diagnostic and treatment services.

Kozower did his thoracic surgery residency at the University of Washington before spending almost a decade at the University of Virginia. He then returned to the University of Washington, rejoining an international leader in cancer research, prevention and treatment.

He earned his medical degree from the University of Rochester in New York and followed it with a general surgery residency at the University of Connecticut.

Kozower is board certified by the American Board of Thoracic Surgery and the American Board of Surgery.

Contact Benjamin Kozower

Specialties of Dr. Benjamin Kozower

  • Pleural and lung cancer
  • Pleural mesothelioma
  • Research
  • Thoracic surgery

Dr. Benjamin Kozower’s Experience and Medical Education

  • University of Rochester (M.D.)
  • University of Virginia (M.P.H.)
  • University of Connecticut (Residency)
  • Washington University School of Medicine (Residency, fellowship)

Awards and Certifications

  • Board certified in surgery and thoracic surgery

Mesothelioma Clinical Trials Under Benjamin Kozower, M.D.

  • A registry for patients with multifocal ground glass opacities (GGOs).
  • Phase I study of induction therapy with VELCADE and vorinostat in patients with surgically resectable non-small cell lung cancer.
  • Post-treatment surveillance in lung cancer.
  • A study of patient-reported outcomes in patients with lung or esophageal cancer.

Publications of Dr. Benjamin Kozower

  • Farjah, F. et al. (2020). Volume Pledge is Not Associated with Better Short-Term Outcomes After Lung Cancer Resection. Journal of Clinical Oncology.
  • Blank, R.S. et al. (2016, June). Management of one-lung ventilation impact of tidal volume on complications after thoracic surgery. Anesthesiology.
  • Kozower, B.D. et al. (2013, May). Special Treatment Issues in Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
  • Kozower, B.D. et al. (2010). STS Database Risk Models: Predictors of Mortality and Major Morbidity for Lung Cancer Resection. The Annals of Thoracic Surgery.

Lab technician using a microscope in a lab
COVID-19 and Mesothelioma Presentation
United States one-hundred-dollar bills
Access More than $32 Billion in Trust Funds
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

  •  
  •  
  •  
Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?